Volatile Anaesthetics Flashcards
Mean Alveolar Concentration
The alveolar concentration of a gaseous agent required to ensure that 50% of a test population at sea level does not respond to a standard surgical skin incision
Dose-response curve for volatile agents
20% below MAC - almost all patients move in response to surgical stimulus
20% above MAC - less than 5% of patients move
Blood:Gas Coefficient
If a substance has a high blood:gas coefficient, it easily dissolves into the blood resulting in a low partial pressure. This results in a slower onset and offset of anaesthesia (paradoxically)
A measure of how quickly Fa/Fi approaches 1 - no units!
Oil:Gas Coefficient
If the Oil:Gas coefficient is high, the substance is more lipid soluble and therefore tends to pass readily into lipid rich organs e.g. the brain. Potency is proportional to O:G (Meyer-Overton)
Factors Decreasing MAC
Pregnancy, neonates, old age Chronic amphetamine use Acute alcohol intoxication Acute opioid use Lithium, benzodiazepines and lidocaine
Factors Increasing MAC
Infancy Acute amphetamine use Hyperthermia, hyperthyroidsim, hypernatraemia Chronic alcoholism Chronic opioid use Catecholamines and sympathomimetics Stress response
Enflurane: MAC
MAC 1.7
Enflurane: Oil:Gas coefficient
O:G 98
Enflurane: Blood:Gas coefficient
B:G 1.9
Isoflurane: MAC
MAC 1.2
Isoflurane: Oil:Gas coefficient
O:G 98
Isoflurane: Blood:Gas coefficient
B:G 1.4
Sevoflurane: MAC
MAC 1.8
Sevoflurane: Oil:Gas coefficient
O:G 80
Sevoflurane: Blood:Gas coefficient
B:G 0.7
Desflurane: MAC
MAC 6.6
Desflurane: Oil:Gas coefficient
O:G 29
Desflurane: Blood:Gas coefficient
B:G 0.4
Halothane: MAC
MAC 0.8
Halothane: Oil:Gas coefficient
O:G 224
Halothane; Blood Gas coefficient
B:G 2.2
Carbon dioxide absorbants
UK: sodium hydroxide USA: potassium hydroxide (baralyme) Requires water H20 + CO2 -> H2CO3 (carbonic acid) H2CO3 + 2NaOH -> Na2CO3 +2H2O Na2CO3 + Ca(OH)2 -> CaCO3 + 2NaOH Sodium carbonate + calcium hydroxide -> Calcium carbonate + sodium hydroxide
Enflurane: structure
Molecular weight: 184
Structural isomer of isoflurane
Isoflurane: structure
Molecular weight: 184
Structural isomer of enflurane
Sevoflurane: structure
Molecular weight: 200
Sevoflurane is achiral
Halothane: structure
Molecular weight: 197
Desflurane: structure
Molecular weight: 168
Desflurane: boiling point
23.5°C (requires specialized Tec 6 vaporizer)
Desflurane: SVP at 20°C
89.2 kPa
Enflurane: boiling point
56.5°C
Enflurane: SVP at 20°C
23.3 kPa
Halothane: boiling point
50.2°C
Halothane: SVP at 20°C
32.3 kPa
Isoflurane: boiling point
48.5°C
Isoflurane: SVP at 20°C
33.2 kPa
Sevoflurane: boiling point
58.5°C
Sevoflurane: SVP at 20°C
22.7 kPa
Desflurane: cardiovascular effects (contractility, heart rate, systemic vascular resistance, blood pressure, coronary steal, splanchic blood flow, catecholemine sensitization)
Contractility: minimal Heart rate: increased (increased ++ at MAC > 1.5). Can induce tachycardia and hypertension at MAC > 1 (classic MCQ question) Systemic vascular resistance: -- Blood pressure: -- Coronary steal: no Splanchic blood flow: unchanged Catecholemine sensitization: nil
Enflurane: cardiovascular effects (contractility, heart rate, systemic vascular resistance, blood pressure, coronary steal, splanchic blood flow, catecholemine sensitization)
Contractility: -- Heart rate: + Systemic vascular resistance: - Blood pressure: -- Coronary steal: No Splanchic blood flow: - Catecholamine sensitization: +
Halothane: cardiovascular effects (contractility, heart rate, systemic vascular resistance, blood pressure, coronary steal, splanchic blood flow, catecholemine sensitization)
Contractility: --- Heart rate: -- Systemic vascular resistance: - Blood pressure: --- Coronary steal: No Splanchic blood flow: - Catecholamine sensitization: +++ (causes arrhythmias)
Isoflurane: cardiovascular effects (contractility, heart rate, systemic vascular resistance, blood pressure, coronary steal, splanchic blood flow, catecholemine sensitization)
Contractility: - Heart rate: ++ (this reflex tachycardia suggests that the carotid sinus reflex is preserved) Systemic vascular resistance: -- Blood pressure: -- Coronary steal: Possibly Splanchic blood flow: Unchanged Catecholamine sensitization: Nil
Sevoflurane: cardiovascular effects (contractility, heart rate, systemic vascular resistance, blood pressure, coronary steal, splanchic blood flow, catecholemine sensitization)
Contractility: - Heart rate: nil effect Systemic vascular resistance: - Blood pressure: - Coronary steal: No Splanchic blood flow: Unchanged Catecholamine sensitization: Nil
The volatile most likely to cause arrhythmia secondary to catecholamine sensitization
Halothane
The volatile most likely to cause coronary steal syndrome
Isoflurane
Desflurane: CNS effects (cerebral blood flow, cerebral O2 requirements, EEG, potentiation of muscle relaxants, analgesia)
Cerebral blood flow: + Cerebral O2 requirements: - EEG: burst supression Potentiation of muscle relaxants: significant Analgesia: some
Isoflurane: CNS effects (cerebral blood flow, cerebral O2 requirements, EEG, potentiation of muscle relaxants, analgesia)
Cerebral blood flow: + (nil if MAC<1)
Cerebral O2 requirements: autoregulation preserved
EEG: burst supression
Potentiation of muscle relaxants: some relaxation
Analgesia: some
Sevoflurane: CNS effects (cerebral blood flow, cerebral O2 requirements, EEG, potentiation of muscle relaxants, analgesia)
Cerebral blood flow: + Cerebral O2 requirements: - EEG: burst supression Potentiation of muscle relaxants: some relaxation Analgesia: some
Enflurane: CNS effects (cerebral blood flow, cerebral O2 requirements, EEG, potentiation of muscle relaxants, analgesia)
Cerebral blood flow: +
Cerebral O2 requirements: -
EEG: Epileptiform activity (3Hz spike and wave)
Potentiation of muscle relaxants: significant
Analgesia: some
Halothane: CNS effects (cerebral blood flow, cerebral O2 requirements, EEG, potentiation of muscle relaxants, analgesia)
Cerebral blood flow: +++ Cerebral O2 requirements: - EEG: burst supression Potentiation of muscle relaxants: some relaxation Analgesia: none
Desflurane: metabolism
0.02%
Enflurane: metabolism
2%
Halothane: metabolism
20%
Can cause Type I (benign, self limiting) or Type II (severe) hepatotoxicity via T-cell mediated inflammation
Metabolism to trifluoroacetic acid under oxidative conditions - implicated in Type II hepatotoxicity
Reductive metabolism to F-C-Br bonds are more easily metabolised than C-F bonds
Isoflurane: metabolism
0.2% - non toxic
NB due to the -CHF2 group, it may react with dry soda lime producing carbon monoxide e.g. in circle system that has been left with dry gas circulating over the weekend
Sevoflurane: metabolism
3.5%
Undergoes hepatic metabolism by cytochrome P450 (isoform 2E1) to produce hexafluoroisopropanol and inorganic fluoride ions (known to cause renal toxicity)
Compound A
Created when sevoflurane is used in the rpesence of carbon dioxide absorbents
More readily produced with (dry) potassium hydroxide
Human nephrotoxic threshold of 150-200 ppm.
At flow rates of 0.25l/min for 5 hours, compound A level < 20ppm (therefore unlikely to cause harm in anaesthesia)
Sevoflurane: manufacture
One pot method - all the ingredients are added together to produce sevoflurane and then water is added to 300ppm
Chloro-fluoro method - basic molecular architecture is manufactured but with chlorine attached. This is then substituted with fluorine
Sevoflurane: respiratory effects
Pleasant odor
Depresses ventilation with reduction in minute volume
Inhibits pulmonary vasoconstriction
Sevoflurane: storage
Can produce hydrofluoric acid if stored in glass or with concentration of added water <100ppm (attack by Lewis acids) - hydorfluoric acid corrodes glass
Therefore formulated with 300ppm water and stored in polyethylene napthalate bottles (alternatively in aluminium bottle with resin laqcuer - can be formulated with <130ppm water)
Halothane: respiratory effects
Sweet, non-irritant odour
Bronchodilatory
High concentrations significantly reduce ventilation